# EDGAR Filing Document

**Accession Number:** 0001540305
**File Stem:** 0001145549-23-004322
**Filing Date:** 2023-1
**Character Count:** 12241
**Document Hash:** 42a3fda970df3507bc32895b3ab82e49
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001145549-23-004322.hdr.sgml**: 20230127

**ACCESSION NUMBER**: 0001145549-23-004322

**CONFORMED SUBMISSION TYPE**: NPORT-P

**PUBLIC DOCUMENT COUNT**: 1

**CONFORMED PERIOD OF REPORT**: 20221130

**FILED AS OF DATE**: 20230127

**DATE AS OF CHANGE**: 20230127

**PERIOD START**: 20221130

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** ETF Series Solutions
- **CENTRAL INDEX KEY:** 0001540305
- **IRS NUMBER:** 000000000
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1112

**FILING VALUES:**
- **FORM TYPE:** NPORT-P
- **SEC ACT:** 1940 Act
- **SEC FILE NUMBER:** 811-22668
- **FILM NUMBER:** 23562420

**BUSINESS ADDRESS:**
- **STREET 1:** 615 EAST MICHIGAN ST
- **CITY:** MILWAUKEE
- **STATE:** WI
- **ZIP:** 53202
- **BUSINESS PHONE:** 414-287-3700

**MAIL ADDRESS:**
- **STREET 1:** 615 EAST MICHIGAN ST
- **CITY:** MILWAUKEE
- **STATE:** WI
- **ZIP:** 53202

## Series and Classes Contracts Data

### PSYK ETF (Series ID: S000072630)

| Class ID   | Class Name   | Ticker Symbol   |
|:---|:---|:---|
| C000229024 | PSYK ETF     | PSYK            |

## Form NPORT-P: Monthly Portfolio Investments Report

### NPORT-P: Part A: General Information

**Item A.1. Information about the Registrant.**

- **a. Name of Registrant:** ETF Series Solutions

- **b. Investment Company Act file number:** 811-22668

- **c. CIK number of Registrant:** 0001540305

- **d. LEI of Registrant:** 5493008BB0X0GYS3UI50

- **e. Address and telephone number of Registrant.**

  - **Street Address 1:** 615 E Michigan Street

  - **City:** Milwaukee

  - **State:** WI

  - **Foreign country:** US

  - **Zip / Postal Code:** 53202

  - **Telephone number:** 414-516-1645

**Item A.2. Information about the Series.**

- **a. Name of Series:** PSYK ETF

- **b. EDGAR series identifier (if any):** S000072630

- **c. LEI of Series:** 549300WSR2ZSYITR2B69

**Item A.3. Reporting period.**

- **a. Date of fiscal year-end:** 2022-11-30

- **b. Date as of which information is reported:** 2022-11-30

**Item A.4. Final filing**

Does the Fund anticipate that this will be its final filing on Form N-PORT? **No**

### Fund Information

**Total Assets:** $2052911.72

**Total Liabilities:** $1442.64

**Net Assets:** $2051469.08

**Monthly Return Information**

| Class               | Month 1 Return (%)   | Month 2 Return (%)   | Month 3 Return (%)   |
|:---|:---|:---|:---|
| Class ID C000229024 | -7.25%               | -5.54%               | 5.97%                |

**Monthly Gains & Losses**

| Period   | Net Realized Gain/Loss   | Net Unrealized Appreciation/Depreciation   |
|:---|:---|:---|
| Month 1  | $-25743.46               | $-92329.97                                 |
| Month 2  | $12924.42                | $-145816.78                                |
| Month 3  | $0.00                    | $116233.78                                 |

### Schedule of Portfolio Investments

| Name                           | Title                                      | Identifiers                                   | Payoff Profile   | Asset Category   | Issuer Category   | Country   |   Balance | Units   | Value (USD)   | % of Net Assets   | Maturity Date   | Coupon Type   | Annualized Rate (%)   | Restricted?   |   Fair Value Level | Lending Status   |
|:---|:---|:---|:---|:---|:---|:---|---:|:---|:---|:---|:---|:---|:---|:---|---:|:---|
| ACADIA Pharmaceuticals Inc     | ACADIA Pharmaceuticals Inc                 | CUSIP: 004225108<br>LEI: 529900O3044NO0PEA039 | Long             | EC               | CORP              | US        |      5842 | NS      | $91018.36     | 4.44%             |  |  |  | No            |                  1 | On Loan: No      |
| AIkido Pharma Inc              | AIkido Pharma Inc                          | CUSIP: 008875304<br>LEI: 549300QQLOI22M69XV87 | Long             | EC               | CORP              | US        |      1219 | NS      | $4168.98      | 0.20%             |  |  |  | No            |                  1 | On Loan: No      |
| Biogen Inc                     | Biogen Inc                                 | CUSIP: 09062X103<br>LEI: W8J5WZB5IY3K0NDQT671 | Long             | EC               | CORP              | US        |       496 | NS      | $151364.32    | 7.38%             |  |  |  | No            |                  1 | On Loan: No      |
| Compass Pathways Plc           | Compass Pathways Plc                       | CUSIP: 20451W101<br>LEI: 213800N7CUZIC6QSTZ31 | Long             | EC               | CORP              | GB        |      6188 | NS      | $63736.40     | 3.11%             |  |  |  | No            |                  1 | On Loan: No      |
| Denali Therapeutics Inc        | Denali Therapeutics Inc                    | CUSIP: 24823R105<br>LEI: 549300ZTQ2HO18L3Q830 | Long             | EC               | CORP              | US        |      3228 | NS      | $103005.48    | 5.02%             |  |  |  | No            |                  1 | On Loan: No      |
| First American Government Obli | First American Government Obligations Fund | CUSIP: 31846V336<br>LEI: 549300R5MYM6VZF1RM44 | Long             | STIV             | RF                | US        |     13982 | NS      | $13982.38     | 0.68%             |  |  |  | No            |                  1 | On Loan: No      |
| Intra-Cellular Therapies Inc   | Intra-Cellular Therapies Inc               | CUSIP: 46116X101<br>LEI: 5299002U2KGF193IJA20 | Long             | EC               | CORP              | US        |      3483 | NS      | $188848.26    | 9.21%             |  |  |  | No            |                  1 | On Loan: No      |
| Johnson & Johnson              | Johnson & Johnson                          | CUSIP: 478160104<br>LEI: 549300G0CFPGEF6X2043 | Long             | EC               | CORP              | US        |       378 | NS      | $67284.00     | 3.28%             |  |  |  | No            |                  1 | On Loan: No      |
| UCB SA                         | UCB SA                                     | CUSIP: N/A<br>LEI: 2138008J191VLSGY5A09       | Long             | EC               | CORP              | BE        |      1394 | NS      | $110205.23    | 5.37%             |  |  |  | No            |                  1 | On Loan: No      |
| Mind Medicine MindMed Inc      | Mind Medicine MindMed Inc                  | CUSIP: 60255C885<br>LEI: 549300QY8KN1O6RPFJ13 | Long             | EC               | CORP              | US        |      6620 | NS      | $16881.00     | 0.82%             |  |  |  | No            |                  1 | On Loan: No      |
| Myriad Genetics Inc            | Myriad Genetics Inc                        | CUSIP: 62855J104<br>LEI: 52990044IHUOUMETT163 | Long             | EC               | CORP              | US        |      7352 | NS      | $148951.52    | 7.26%             |  |  |  | No            |                  1 | On Loan: No      |
| NRX Pharmaceuticals Inc        | NRX Pharmaceuticals Inc                    | CUSIP: 629444100<br>LEI: 5493003FN4CLS0670T77 | Long             | EC               | CORP              | US        |     15730 | NS      | $22651.20     | 1.10%             |  |  |  | No            |                  1 | On Loan: No      |
| Neurocrine Biosciences Inc     | Neurocrine Biosciences Inc                 | CUSIP: 64125C109<br>LEI: 549300FECER0XBN49756 | Long             | EC               | CORP              | US        |       939 | NS      | $119309.34    | 5.82%             |  |  |  | No            |                  1 | On Loan: No      |
| Relmada Therapeutics Inc       | Relmada Therapeutics Inc                   | CUSIP: 75955J402<br>LEI: 549300217EASRZ9JSF81 | Long             | EC               | CORP              | US        |      4748 | NS      | $22078.20     | 1.08%             |  |  |  | No            |                  1 | On Loan: No      |
| Sage Therapeutics Inc          | Sage Therapeutics Inc                      | CUSIP: 78667J108<br>LEI: 5493000JX4BJS9W6CN35 | Long             | EC               | CORP              | US        |      4078 | NS      | $167361.12    | 8.16%             |  |  |  | No            |                  1 | On Loan: No      |
| Sarepta Therapeutics Inc       | Sarepta Therapeutics Inc                   | CUSIP: 803607100<br>LEI: 549300IKDPIED8J8IG21 | Long             | EC               | CORP              | US        |       872 | NS      | $107090.32    | 5.22%             |  |  |  | No            |                  1 | On Loan: No      |
| Seelos Therapeutics Inc        | Seelos Therapeutics Inc                    | CUSIP: 81577F109<br>LEI: 5493009HV8O6R1WGZ132 | Long             | EC               | CORP              | US        |     24810 | NS      | $20309.47     | 0.99%             |  |  |  | No            |                  1 | On Loan: No      |
| Tonix Pharmaceuticals Holding  | Tonix Pharmaceuticals Holding Corp         | CUSIP: 890260862<br>LEI: 529900ACPKP9QW20GX48 | Long             | EC               | CORP              | US        |     10271 | NS      | $3954.34      | 0.19%             |  |  |  | No            |                  1 | On Loan: No      |
| VistaGen Therapeutics Inc      | VistaGen Therapeutics Inc                  | CUSIP: 92840H202<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     48099 | NS      | $6642.47      | 0.32%             |  |  |  | No            |                  1 | On Loan: No      |
| Zynerba Pharmaceuticals Inc    | Zynerba Pharmaceuticals Inc                | CUSIP: 98986X109<br>LEI: 549300JLJ5VQU2CN6016 | Long             | EC               | CORP              | US        |     10640 | NS      | $5716.87      | 0.28%             |  |  |  | No            |                  1 | On Loan: No      |
| H Lundbeck A/S                 | H Lundbeck A/S                             | CUSIP: N/A<br>LEI: 5493006R4KC2OI5D3470       | Long             | EC               | CORP              | DK        |     23923 | NS      | $83041.82     | 4.05%             |  |  |  | No            |                  1 | On Loan: No      |
| H Lundbeck A/S                 | H Lundbeck A/S                             | CUSIP: N/A<br>LEI: 5493006R4KC2OI5D3470       | Long             | EC               | CORP              | DK        |     24274 | NS      | $88746.26     | 4.33%             |  |  |  | No            |                  1 | On Loan: No      |
| Alkermes PLC                   | Alkermes PLC                               | CUSIP: N/A<br>LEI: N/A                        | Long             | EC               | CORP              | IE        |      3972 | NS      | $98426.16     | 4.80%             |  |  |  | No            |                  1 | On Loan: No      |
| Biohaven Ltd                   | Biohaven Ltd                               | CUSIP: N/A<br>LEI: N/A                        | Long             | EC               | CORP              | US        |       590 | NS      | $9333.80      | 0.45%             |  |  |  | No            |                  1 | On Loan: No      |
| GH Research PLC                | GH Research PLC                            | CUSIP: N/A<br>LEI: 875500HKJS7QQG6EWH62       | Long             | EC               | CORP              | IE        |      7529 | NS      | $82367.26     | 4.02%             |  |  |  | No            |                  1 | On Loan: No      |
| Jazz Pharmaceuticals PLC       | Jazz Pharmaceuticals PLC                   | CUSIP: N/A<br>LEI: 635400GAUMJCLEZRRV50       | Long             | EC               | CORP              | IE        |      1086 | NS      | $170404.26    | 8.31%             |  |  |  | No            |                  1 | On Loan: No      |
| ATAI Life Sciences NV          | ATAI Life Sciences NV                      | CUSIP: N/A<br>LEI: 391200Z8UWPJSNBNCA11       | Long             | EC               | CORP              | DE        |     24171 | NS      | $85323.63     | 4.16%             |  |  |  | No            |                  1 | On Loan: No      |

### Signature

**Date Signed:** 2023-01-27

**Name of Applicant:** ETF Series Solutions

**Signature:** /s/ Kristen Weitzel

**Name of Signer:** ETF Series Solutions

**Title:** Treasurer